| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |